ONCOZ · OncoZenge AB · Insider Trading
Transactions in OncoZenge AB securities by directors, senior managers and their closely associated persons, as published by the market regulator under the EU Market Abuse Regulation.
Director and related-person transactions
Source-reported director and related-person transactions, including amendments and historical rows. Not a complete insider-ownership register. Coverage is limited to captured publication days; gaps may exist between the first and last day. A verified issuer LEI includes other instruments of that issuer; an ISIN-only match covers that security. Instrument types and transaction descriptions are retained verbatim; do not sum revised, historical or derivative rows as share purchases. Publication timestamps are local source times.
| Transaction date | Person | Transaction | Instrument | Volume | Price | Status |
|---|---|---|---|---|---|---|
| 2026-09-18 | Paul Murtagh Member of the Board of Directors | Subscription | Oncozenge AB BTA BTA · SE0015504097 | 118500 Quantity | 3 SEK | Current |
| 2026-09-18 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Subscription | OncoZenge AB BTA BTA · SE0030264628 | 375000 Quantity | 3 SEK | Current |
| 2026-09-23 | Per Daniel Ehrenstråhle Chairman of the Board of Directors | Acquisition | ONCOS BTA BTA · SE0030264628 | 100000 Quantity | 3 SEK | Current |
| 2026-09-06 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Allotment | Teckningsoption av serie 2026/2028:2 Subcription warrant · | 1000000 Quantity | 0.207 SEK | Current |
| 2026-09-06 | Per Daniel Ehrenstråhle Chairman of the Board of Directors | Allotment | Teckningsoption av serie 2026/2028:1 Subcription warrant · | 1000000 Quantity | 0.207 SEK | Current |
| 2026-08-28 | Paul Murtagh Member of the Board of Directors | Acquisition | OncoZenge AB Share · SE0015504097 | 20000 Quantity | 5.05 SEK | Current |
| 2026-08-27 | Paul Murtagh Member of the Board of Directors | Acquisition | OncoZenge AB Share · SE0015504097 | 18000 Quantity | 5.3 SEK | Current |
| 2025-11-28 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 74999 Quantity | 5.3 SEK | Current |
| 2025-09-09 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 25000 Quantity | 6.3 SEK | Current |
| 2025-08-26 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 25001 Quantity | 6.94 SEK | Current |
| 2025-06-25 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 25000 Quantity | 5.7 SEK | Current |
| 2025-04-07 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 20439 Quantity | 4.16 SEK | Current |
| 2025-03-28 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 20000 Quantity | 5.91 SEK | Current Uppdaterat handelsplats |
| 2025-03-28 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 20000 Quantity | 5.91 SEK | Revised |
| 2024-11-21 | Niclas Holmgren Member of the Board of Directors | Acquisition | OncoZenge AB Share · SE0015504097 | 56635 Quantity | 3.53 SEK | Current |
| 2024-11-18 | Niclas Holmgren Member of the Board of Directors | Acquisition | OncoZenge AB Share · SE0015504097 | 30000 Quantity | 10.56 SEK | Current |
| 2024-05-06 | Niclas Holmgren Member of the Board of Directors | Inheritance received | OncoZenge AB Share · SE0015504097 | 100000 Quantity | 3.945 SEK | Current |
| 2024-01-09 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 25000 Quantity | 3.16 SEK | Current |
| 2023-11-15 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 25000 Quantity | 2.786 SEK | Current |
| 2023-11-02 | Christoph Nowak Member of the Board of Directors | Acquisition | Teckningsoption av serie 2023/2025:1 Subcription warrant · | 350000 Quantity | 0.368 SEK | Current |
| 2023-11-01 | Per Daniel Ehrenstråhle Chairman of the Board of Directors | Acquisition | Teckningsoption av serie 2023/2025:1 Subcription warrant · | 350000 Quantity | 0.368 SEK | Current |
| 2023-11-01 | Niclas Holmgren Member of the Board of Directors | Acquisition | Teckningsoption av serie 2023/2025:1 Subcription warrant · | 350000 Quantity | 0.368 SEK | Current |
| 2023-11-01 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Acquisition | 2023/2025:2 Subcription warrant · | 500000 Quantity | 0.368 SEK | Current |
| 2023-09-21 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 40000 Quantity | 3.1 SEK | Current |
| 2023-09-20 | Stian Kildal Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 60000 Quantity | 2.91 SEK | Current |
| 2021-03-08 | Mattias Klintemar Member of the Board of Directors | Exercise decrease | OncoZenge Teckningsrätt (som förfallit och inte untyttjats - kan inte fylla i noll under "volym") Subscription right/Unit right · | 1 Quantity | 0 SEK | Current |
| 2021-03-08 | Torben Mogensen Member of the Board of Directors | Subscription | OncoZenge BTA BTA · SE0015531231 | 10633 Quantity | 10.25 SEK | Current Forkert namn på firma, namn ändret. Ikke aktier men BTA ændret ISIN-kod |
| 2021-03-08 | Torben Mogensen Member of the Board of Directors | Subscription | Aktie Share · SE0015504097 | 10633 Quantity | 10.25 SEK | Revised Forkert namn på firma, namn ändret. |
| 2021-03-05 | Pirkko Vilja Päivikki Sulila Tamsen Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | OncoZenge Subscription Rights Subscription right/Unit right · SE0015531223 | 335 Quantity | 0 SEK | Current |
| 2021-03-08 | Torben Mogensen Member of the Board of Directors | Subscription | Aktie Share · SE0015504097 | 10633 Quantity | 10.25 SEK | Revised |
| 2021-03-08 | Anna Helena Constance Ljung Chairman of the Board of Directors | Subscription | OncoZenge BTA BTA · SE0015531231 | 9757 Quantity | 10.25 SEK | Current |
| 2021-03-05 | Hilde Furberg Member of the Board of Directors | Subscription | OncoZenge AB BTA BTA · SE0015531231 | 14635 Quantity | 10.25 SEK | Current ny Lei och bolagsnamn och transaktionens karakter |
| 2021-03-05 | Pirkko Vilja Päivikki Sulila Tamsen Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 13900 Quantity | 11.11 SEK | Current Plats för transaktionen |
| 2021-03-05 | Pirkko Vilja Päivikki Sulila Tamsen Chief Executive Officer (CEO)/Managing Directory | Subscription | OncoZenge AB BTA BTA · SE0015531231 | 20000 Quantity | 10.25 SEK | Current Plats för transaktionen |
| 2021-03-05 | Cindy Wong Other member of the company's administrative, management or supervisory body | Subscription | OncoZenge BTA BTA · SE0015531231 | 20000 Quantity | 10.25 SEK | Current |
| 2021-03-02 | Pirkko Vilja Päivikki Sulila Tamsen Chief Executive Officer (CEO)/Managing Directory | Disposal | OncoZenge AB TR Subscription right/Unit right · SE0015531223 | 134086 Quantity | 1.15 SEK | Current Plats för transaktionen |
| 2021-02-19 | Hilde Furberg Member of the Board of Directors | Acquisition | Subscription right OncoZenge Subscription right/Unit right · SE0015531223 | 14635 Quantity | 0 SEK | Current ny Lei och bolagsnamn |
| 2021-02-19 | Pirkko Vilja Päivikki Sulila Tamsen Chief Executive Officer (CEO)/Managing Directory | Disposal | OncoZenge AB TR Subscription right/Unit right · SE0015531223 | 41135 Quantity | 0 SEK | Current Plats för transaktionen |
| 2021-03-05 | Pirkko Vilja Päivikki Sulila Tamsen Chief Executive Officer (CEO)/Managing Directory | Subscription | OncoZenge AB BTA BTA · SE0015531231 | 20000 Quantity | 10.25 SEK | Revised |
| 2021-03-05 | Pirkko Vilja Päivikki Sulila Tamsen Chief Executive Officer (CEO)/Managing Directory | Acquisition | OncoZenge AB Share · SE0015504097 | 13900 Quantity | 11.11 SEK | Revised |
| 2021-03-05 | Mark Beveridge Chief Financial Officer (CFO) | Subscription | OncoZenge AB BTA BTA · SE0015531231 | 15000 Quantity | 10.25 SEK | Current |
| 2021-03-02 | Pirkko Vilja Päivikki Sulila Tamsen Chief Executive Officer (CEO)/Managing Directory | Disposal | OncoZenge AB TR Subscription right/Unit right · SE0015531223 | 134086 Quantity | 1.15 SEK | Revised |
| 2021-03-02 | Mark Beveridge Chief Financial Officer (CFO) | Disposal | OncoZenge Subscription Rights Subscription right/Unit right · SE0015531223 | 9259 Quantity | 1.2 SEK | Current |
| 2021-03-02 | Mark Beveridge Chief Financial Officer (CFO) | Acquisition | OncoZenge Subscription Rights Subscription right/Unit right · SE0015531223 | 9259 Quantity | 1.2 SEK | Current |
| 2021-03-02 | Mark Beveridge Chief Financial Officer (CFO) | Disposal | OncoZenge Subscription Rights Subscription right/Unit right · SE0015531223 | 15144 Quantity | 1.1 SEK | Current |
| 2021-02-19 | Pirkko Vilja Päivikki Sulila Tamsen Chief Executive Officer (CEO)/Managing Directory | Disposal | OncoZenge AB TR Subscription right/Unit right · SE0015531223 | 41135 Quantity | 0 SEK | Revised |
| 2021-02-19 | Cindy Wong Other member of the company's administrative, management or supervisory body | Acquisition | OncoZenge Teckningsrätt Subscription right/Unit right · SE0015531223 | 20000 Quantity | 0 SEK | Current |
3748 publication days captured; dates between 2016-07-03 and 2026-10-08 may contain gaps. Checked 2026-10-08 22:11 UTC.